# SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

> **NCT01445392** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 24 (actual)

## Conditions studied

- Mesothelioma

## Interventions

- **BIOLOGICAL:** Multicycle SS1P
- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin
- **BIOLOGICAL:** Single cycle SS1P

## Key facts

- **NCT ID:** NCT01445392
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11-14
- **Primary completion:** 2014-01-31
- **Final completion:** 2016-10-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01445392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01445392, "SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01445392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*